Abstract:Molecular recognition is fundamental in biology, underpinning intricate processes through specific protein–ligand interactions. This understanding is pivotal in drug discovery, yet traditional experimental methods face limitations in exploring the vast chemical space. Computational approaches, notably quantitative structure–activity/property relationship analysis, have gained prominence. Molecular fingerprints encode molecular structures and serve as property profiles, which are essential in drug discovery. While two-dimensional (2D) fingerprints are commonly used, three-dimensional (3D) structural interaction fingerprints offer enhanced structural features specific to target proteins. Machine learning models trained on interaction fingerprints enable precise binding prediction. Recent focus has shifted to structure-based predictive modeling, with machine-learning scoring functions excelling due to feature engineering guided by key interactions. Notably, 3D interaction fingerprints are gaining ground due to their robustness. Various structural interaction fingerprints have been developed and used in drug discovery, each with unique capabilities. This review recapitulates the developed structural interaction fingerprints and provides two case studies to illustrate the power of interaction fingerprint-driven machine learning. The first elucidates structure–activity relationships in β2 adrenoceptor ligands, demonstrating the ability to differentiate agonists and antagonists. The second employs a retrosynthesis-based pre-trained molecular representation to predict protein–ligand dissociation rates, offering insights into binding kinetics. Despite remarkable progress, challenges persist in interpreting complex machine learning models built on 3D fingerprints, emphasizing the need for strategies to make predictions interpretable. Binding site plasticity and induced fit effects pose additional complexities. Interaction fingerprints are promising but require continued research to harness their full potential.

Computer Modeling for Interaction of Ligands and Receptors and Their Applications in Drug Design

Quantitative Structure–activity Relationship: Promising Advances in Drug Discovery Platforms

Advances in Computational Structure-Based Drug Design and Application in Drug Discovery.

Advances in Modeling of Biomolecular Interactions

Recent Trends and Applications of Molecular Modeling in GPCR–Ligand Recognition and Structure-Based Drug Design

Current Developments of Computer-Aided Drug Design

Computational modeling of structure-function of g protein-coupled receptors with applications for drug design.

Molecular Docking and Structure-Based Drug Design Strategies

Simulation Studies Of Protein And Small Molecule Interactions And Reaction

Molecular docking as a popular tool in drug design, an in silico travel

The Emergence of In-Silico Models in Drug Target Interaction System: A Comprehensive Review

Polymer membrane and cell models for drug discovery.

Integrated Molecular Modeling and Machine Learning for Drug Design

Insights into Intercellular Receptor-Ligand Binding Kinetics in Cell Communication.

Study on human GPCR-inhibitor interactions by proteochemometric modeling.

Fingerprinting Interactions between Proteins and Ligands for Facilitating Machine Learning in Drug Discovery

Structure-based drug design: NMR-based approach for ligand-protein interactions.

Intercellular Receptor-ligand Binding: Effect of Protein-membrane Interaction.

A Practical Guide to Molecular Docking and Homology Modelling for Medicinal Chemists

Structure-based drug design: From nucleic acid to membrane protein targets

Molecular modeling: A powerful tool for drug design and molecular docking